Form 4: Relay Therapeutics' Chief Legal Officer Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Brian Adams, Chief Legal Officer of Relay Therapeutics, sold 1,632 shares of common stock on October 28, 2024, to cover income tax withholding obligations upon the vesting of restricted stock units.
Summary
- Brian Adams, the Chief Legal Officer of Relay Therapeutics, Inc. (RLAY), sold 1,632 shares of common stock on October 28, 2024.
- The sale was executed at a price of $6.06 per share.
- This transaction was to cover income tax withholding obligations related to the vesting of 5,506 restricted stock units (RSUs) on October 27, 2024.
- Following the transaction, Adams beneficially owns 321,907 shares of Relay Therapeutics, Inc., which includes 278,325 shares underlying RSUs.
Sentiment
Score: 5
Explanation: This is a neutral event. It's a routine transaction related to tax obligations and doesn't indicate a significant change in the company's prospects or management's confidence.
Industry Context
This is a routine transaction related to executive compensation and tax obligations, common in publicly traded companies. It doesn't necessarily reflect a change in the executive's confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 10/27/2024 | Vesting of 5,506 shares of restricted stock units (RSUs). |
| 10/28/2024 | Sale of 1,632 shares of common stock by Brian Adams. |
| 10/30/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.